SCHEMBL8091799

SCHEMBL8091799

CN(C)P(=O)(F)N(C)C.COCCOC

nearest known ligand 0.34

Predicted protein targets (top 2)

geneUniProtsupporting neighboursconfidence
CA2 P00918 1/20 0.34
PIK3CD O00329 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6739890 0.82
SCHEMBL118899 0.82
Water SCHEMBL29412656 0.78
Methylene Chloride SCHEMBL1604482 0.77 HTT (0.30)
SCHEMBL5493310 0.77 PIK3CD (0.33) CA2PIK3CD
Trimethylammonium SCHEMBL25390275 0.71 PIK3CD (0.41) PIK3CD
Diethylamine SCHEMBL17396366 0.70 TP53 (0.42)
SCHEMBL9351980 0.70 CA2 (0.38) CA2PIK3CD
SCHEMBL908858 0.69 CTSA (0.33)
SCHEMBL1009857 0.69

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6040311-A TREATING BONE DISORDERS FOR PREVENTING OSTEOPOROSIS OR INHIBITING BONE RESORPTION IN A MAMMAL; TREATING TUMOR GROWTH IN A MAMMAL MERCK & CO., INC. (US) 2000-03-21 US disclosed
US-5952341-A VITRONECTIN RECEPTOR ANTAGONISTS FOR INHIBITING BONE RESORPTION, TREATING AND PREVENTING OSTEOPOROSIS, AND INHIBITING RESTENOSIS, DIABETIC RETINOPATHY, TUMOR, MACULAR DEGENERATION, ANGIOGENESIS, ATHEROSCLEROSIS, INFLAMMATION MERCK & CO., INC. (US) 1999-09-14 US disclosed